Local recurrences of salivary gland tumors in a Brazilian population
DOI:
https://doi.org/10.11606/issn.2357-8041.clrd.2022.194477Keywords:
Salivary gland neoplasms, Neoplasm metastasis, PrognosisAbstract
Objective: To identify the recurrence after surgery in patients diagnosed with salivary gland tumor. Methods: Data on age, gender, type of salivary gland tumor, local recurrence, stage, primary site and type of treatment were collected at Hospital de Câncer de Pernambuco, Recife, Brazil, using a standard form based on clinical records. These were described and analyzed with a significance level of 5% (p < 0.05). Results: Of the 55 medical records that comprised the study sample, 51% were male. Overall mean age was 55 years, ranging from 13 to 90 years. Adenocarcinoma (NOS) was the most prevalent (n = 17), followed by adenoid cystic carcinoma (ACC) (n = 14; 25.5%). Among all sites, parotid gland (n = 29; 53%) was the most common. Among the patients studied, 61.8% (n = 34) had no distant metastasis, but 38.18% (n = 21) did, and 14.55% (n = 8) showed bone metastasis. Conversely, 34.55% (n = 19) of the patients had recurrence only one year after diagnosis. The neoplasm with the highest recurrence rate was NOS (n = 17, 30.91%), followed by CAC (n = 14, 25.45%). Conclusion: Results show a prevalence of male patients and parotid gland involvement, with NOS adenocarcinoma and CAC being the most frequent neoplasms. Distant metastasis occurred in 38.18% (n = 21) of the cases, and bone was the most affected site. Surgery with adjuvant radiotherapy (n = 15) was the treatment of choice.
Downloads
References
Carlson ER, Schlieve T. Salivary gland malignancies. Oral Maxillofac Surg Clin North Am. 2019;31(1):125-44. Doi: https://doi.org/10.1016/j.coms.2018.08.007.
Shen SY, Wang WH, Liang R, Pan GQ, Qian YM. Clinicopathologic analysis of 2736 salivary gland cases over a 11-year period in Southwest China. Acta Otolaryngol. 2018;138(8):746-9. Doi: https://doi.org/10.1080/00016489.2018.1455108.
Santana BW, Silva LP, Serpa MS, Borges MD, Moura SR, Silveira MM, et al. Incidence and profile of benign epithelial tumors of salivary glands from a single center in Northeast of Brazil. Med Oral Patol Oral Cir Bucal. 2021;26(1):e108-13. Doi: https://doi.org/10.4317/medoral.24056.
Gao M, Hao Y, Huang MX, Ma DQ, Chen Y, Luo HY, et al. Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases. Int J Oral Maxillofac Surg. 2017;46(3):343-9. Doi: https://doi.org/10.1016/j.ijom.2016.09.021.
Fonseca FP, Carvalho MV, Almeida OP, Rangel AL, Takizawa MC, Bueno AG, et al. Clinicopathologic analysis of 493 cases of salivary gland tumors in a Southern Brazilian population. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):230-9. Doi: https://doi.org/10.1016/j.oooo.2012.04.008.
Slootweg PJ, El-Naggar AK. World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications. Virchows Arch. 2018;472(3):311-3. Doi: https://doi.org/10.1007/s00428-018-2320-6.
Wang X, Luo Y, Li M, Yan H, Sun M, Fan T. Management of salivary gland carcinomas – a review. Oncotarget. 2017;8(3):3946-56. Doi: https://doi.org/10.18632%2Foncotarget.13952.
Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8(3):177-84. Doi: https://doi.org/10.1002/hed.2890080309.
Pinheiro J, Sá Fernandes M, Pereira AR, Lopes JM. Histological subtypes and clinical behavior evaluation of salivary gland tumors. Acta Med Port. 2018;31(11):641-7. Doi: https://doi.org/10.20344/amp.9023.
Bittar RF, Ferraro HP, Moraes Gonçalves FT, Couto da Cunha MG, Biamino ER. Neoplasms of the salivary glands: analysis of 727 histopathological reports in a single institution. Otolaryngol Pol. 2015;69(4):28-33. Doi: https://doi.org/10.5604/00306657.1163578.
da Silva LP, Serpa MS, Viveiros SK, Sena DA, de Carvalho Pinho RF, de Abreu Guimarães LD, et al. Salivary gland tumors in a Brazilian population: a 20-year retrospective and multicentric study of 2292 cases. J Craniomaxillofac Surg. 2018;46(12):2227-33. Doi: https://doi.org/10.1016/j.jcms.2018.09.028.
Campolo González A, Ramírez Skinner H, Vargas Díaz A, León Ramírez A, Goñi Espildora I, Solar González A. Perfil epidemiológico de neoplasias epiteliales de glándulas salivales. Rev Med Chil. 2018;146(10):1159-66. Doi: http://dx.doi.org/10.4067/S0034-98872018001001159.
Wang XD, Meng LJ, Hou TT, Huang SH. Tumours of the salivary glands in northeastern China: a retrospective study of 2508 patients. Br J Oral Maxillofac Surg. 2015;53(2):132-7. Doi: https://doi.org/10.1016/j.bjoms.2014.10.008.
Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010;39(3):235-42. Doi: https://doi.org/10.1016/j.ijom.2009.10.016.
Sarmento DJ, Morais ML, Costa AL, Silveira EJ. Minor intraoral salivary gland tumors: a clinical-pathological study. Einstein (Sao Paulo). 2016;14(4):508-12. Doi: https://doi.org/10.1590/S1679-45082016AO3749.
Iqbal N, Iqbal N. Imatinib: a breakthrough of targeted therapy in cancer. Chemother Res Pract. 2014;2014:357027. Doi: https://doi.org/10.1155/2014/357027.
Vasconcelos AC, Nör F, Meurer L, Salvadori G, Souza LB, Vargas PA, et al. Clinicopathological analysis of salivary gland tumors over a 15-year period. Braz Oral Res. 2016;30:S1806-83242016000100208. Doi: https://doi.org/10.1590/1807-3107BOR-2016.vol30.0002.
Abrahão AC, Santos Netto JN, Pires FR, Santos TC, Cabral MG. Clinicopathological characteristics of tumours of the intraoral minor salivary glands in 170 Brazilian patients. Br J Oral Maxillofac Surg. 2016;54(1):30-4. Doi: https://doi.org/10.1016/j.bjoms.2015.10.035.
Li TI, Chiang MT, Chiu KC, Lai CH, Liu SY, Shieh YS. The association of betel quid, alcohol, and cigarettes with salivary gland tumor-A case-control study. J Dent Sci. 2017;12(2):151-5. Doi: https://doi.org/10.1016/j.jds.2016.12.002.
Szewczyk M, Golusiński P, Pazdrowski J, Pieńkowski P, Marszałek S, Sygut J, et al. Patterns of treatment failure in salivary gland cancers. Rep Pract Oncol Radiother. 2018;23(4):260-5. Doi: https://dx.doi.org/10.1016%2Fj.rpor.2018.05.004.
Pacheco-Ojeda L, Domeisen H, Narvaez M, Tixi R, Vivar N. Malignant salivary gland tumors in Quito, Ecuador. ORL J Otorhinolaryngol Relat Spec. 2000;62(6):296-302. Doi: https://doi.org/10.1159/000027772.
Rajappa SK, Bhakuni YS, Ram D, Shukla H, Ranjan R, Dewan A, et al. A gland of diverse pathology and unpredictable behaviour: our experience of primary submandibular gland malignancies. Int J Oral Maxillofac Surg. 2018;47(10):1243-9. Doi: https://doi.org/10.1016/j.ijom.2018.05.012.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Maria Eduarda de Arruda Lucena, Hittalo Carlos Rodrigues de Almeida, Leorik Pereira da Silva, Márcia Maria Fonseca da Silveira, Ana Paula Veras Sobral

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are requested to send, together with the letter to the Editors, a term of responsibility. Thus, the works submitted for appreciation for publication must be accompanied by a document containing the signature of each of the authors, the model of which is presented as follows:
I/We, _________________________, author(s) of the work entitled_______________, now submitted for the appreciation of Clinical and Laboratorial Research in Dentistry, agree that the authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Date: ____/____/____Signature(s): _______________